Realm Therapeutics (RLM)

Sector:

Health Care

Trade now with BarclaysStockbrokers Trade now with Barclays Sponsored by Barclays Stockbrokers

 43.50p
   
  • Change Today:
      0.000p
  • 52 Week High: 45.00
  • 52 Week Low: 26.00
  • Currency: UK Pounds
  • Shares Issued: 116.56m
  • Volume: 8,777
  • Market Cap: 50.70m

RLM Overview

Realm Therapeutics is an emerging specialty biopharmaceutical company focused on developing novel immunomodulatory therapies to protect and improve the lives of adults and children. The Company has initiated drug development programmes, based on its proprietary hypochlorous acid technology at high concentrations. The Company believes their formulations have novel immunomodulatory activity with potential application for the treatment of diseases in a number of therapeutic areas including Dermatology and Ophthalmology.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn -83.9% -1705.0%
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue 76.9 75.4
Pr/Book 3.5  
Latest F'cast
Revenue -29.3% -41.3%
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

RLM Fundamentals

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-12 47.36 (3.15) (4.00)¢ n/a n/a n/a n/a 0.0%
31-Dec-13 31.46 (8.62) (6.00)¢ n/a n/a n/a n/a 0.0%
31-Dec-14 17.15 (7.02) (0.14)¢ n/a n/a n/a n/a 0.0%
31-Dec-15 1.23 (5.20) (0.10)¢ n/a n/a n/a n/a 0.0%
31-Dec-16 0.87 (7.30) (0.15)¢ n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

RLM Forecasts

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-17 0.67 (11.47) (22.88)p n/a n/a n/a n/a 0.0%
31-Dec-18 4.43 (16.67) (20.60)p n/a n/a n/a n/a 0.0%

Copyright © 2017 FactSet Research Systems Inc. All rights reserved.

RLM Company Announcements

Holding(s) in Company 18-Oct-2017 07:00 RNS
Block Listing Application 18-Oct-2017 07:00 RNS
Holding(s) in Company 17-Oct-2017 18:28 RNS

Latest RLM Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

RLM Market Data

Currency UK Pounds
Share Price 43.50p
Change Today 0.000p
% Change 0.00 %
52 Week High 45.00
52 Week Low 26.00
Volume 8,777
Shares Issued 116.56m
Market Cap 50.70m

RLM Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
11.1% below the market average11.1% below the market average11.1% below the market average11.1% below the market average11.1% below the market average
6.67% below the sector average6.67% below the sector average6.67% below the sector average6.67% below the sector average6.67% below the sector average
Price Trend
90.59% above the market average90.59% above the market average90.59% above the market average90.59% above the market average90.59% above the market average
75.00% above the sector average75.00% above the sector average75.00% above the sector average75.00% above the sector average75.00% above the sector average
Income Not Available
Growth
67.29% below the market average67.29% below the market average67.29% below the market average67.29% below the market average67.29% below the market average
93.1% below the sector average93.1% below the sector average93.1% below the sector average93.1% below the sector average93.1% below the sector average

RLM Dividends

No dividends found

Trades for 23-Oct-2017

Time Volume / Share Price
12:00 1,000 @ 45.00p
12:00 1,000 @ 45.00p
10:54 7,777 @ 45.00p
10:54 7,777 @ 45.00p

Top of Page